Please assess the completion status of the following clinical trial:

Trial Title: Trial of Cooling for Patients With Excel Cryo Cooling System in Intracerebral Hemorrhage (ICH)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients with brain injury in the Neurological ICU.~2. Consent from the patient or surrogate decision maker.~3. Warfarin induced intracerebral hemorrhages only after correction of INR to \<1.4.~Exclusion Criteria:~1. Cerebellar hemorrhages.~2. Moribund state where the physician team doesn't believe the patient will survive.~3. Patients who are being cared for with the intent of making them comfortable. DNR-CC (by Ohio law).~4. Known history of a blood dyscrasia such as CLL or essential thrombocytosis that could affect inflammation.~5. Known significant carotid artery stenosis (known \>50% stenosis by history or incidental hospital imaging). This will not be specifically tested. Patients found to have significant stenosis later in the hospital stay will have their data interpreted separately as well as in the total group.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Excel Cryo Cooling System Collar (Type: OTHER): An Excel Cryo Cooling System collar will be placed around the neck for a 2 hour neck cooling period. This will cool the blood in the neck that goes to the brain causing the brain to become cool. The collar is a standard neck collar used for patients after neck surgery with a modification that allows for the placement of a cooling pack in the collar. The cooling pack is similar to the cooling packs used for sports injuries. The cooling packs will be changed every 20 minutes for the two-hour duration. During the study and for two hours after, we will collect data concerning the brain temperature, body temperature, brain oxygen level and pressure both in the head and in the blood.

Based on this trial design, predict the completion outcome and termination type (if applicable).